211 related articles for article (PubMed ID: 17593991)
21. Nebivolol: a review of its use in the management of hypertension and chronic heart failure.
Moen MD; Wagstaff AJ
Drugs; 2006; 66(10):1389-409; discussion 1410. PubMed ID: 16903772
[TBL] [Abstract][Full Text] [Related]
22. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
Weiss RJ; Stapff M; Lin Y
Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
[TBL] [Abstract][Full Text] [Related]
23. Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension.
Serg M; Kampus P; Kals J; Zagura M; Zilmer M; Zilmer K; Kullisaar T; Eha J
Scand J Clin Lab Invest; 2012 Sep; 72(5):427-32. PubMed ID: 22708640
[TBL] [Abstract][Full Text] [Related]
24. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
[TBL] [Abstract][Full Text] [Related]
25. Quality of life and antihypertensive effect with nebivolol and losartan.
Van Bortel LM; Bulpitt CJ; Fici F
Am J Hypertens; 2005 Aug; 18(8):1060-6. PubMed ID: 16296572
[TBL] [Abstract][Full Text] [Related]
26. [Pulse pressure, arterial compliance and Buckberg index in hypertensive patients treated with nebivolol and nitrates].
Prisadă OV; Covic A; Arghiri E; Cernomaz A; Ungureanu G
Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):352-7. PubMed ID: 17983167
[TBL] [Abstract][Full Text] [Related]
27. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
[TBL] [Abstract][Full Text] [Related]
28. The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.
Rizos E; Bairaktari E; Kostoula A; Hasiotis G; Achimastos A; Ganotakis E; Elisaf M; Mikhailidis DP
J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):127-34. PubMed ID: 12808486
[TBL] [Abstract][Full Text] [Related]
29. Nebivolol: a review.
Cockcroft J
Expert Opin Pharmacother; 2004 Apr; 5(4):893-9. PubMed ID: 15102571
[TBL] [Abstract][Full Text] [Related]
30. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study.
Redón J; Pascual-Izuel JM; Rodilla E; Vicente A; Oliván J; Bonet J; Torguet JP; Calaforra O; Almirall J
Blood Press; 2014 Jun; 23(3):181-8. PubMed ID: 24059690
[TBL] [Abstract][Full Text] [Related]
31. Use of nebivolol for the treatment of endothelial dysfunction in patients with hypertension: the EDEN registry.
Masoli O; Redruello M; Baliño NP; Grynberg L; Sonia T; Collaud C; Md LV
J Cardiovasc Pharmacol; 2008 Feb; 51(2):202-7. PubMed ID: 18287889
[TBL] [Abstract][Full Text] [Related]
32. [Prospective follow-up of nebivolol in the treatment of arterial hypertension].
Despotović N; Matić-Cvetković D; Ivanović B
Srp Arh Celok Lek; 2012; 140(7-8):425-30. PubMed ID: 23092025
[TBL] [Abstract][Full Text] [Related]
33. [Use of nebivolol in patients with mild and moderate hypertension].
Zhigunova LV; Lakhova EL; Iurenev AP
Ter Arkh; 2003; 75(3):59-61. PubMed ID: 12718224
[TBL] [Abstract][Full Text] [Related]
34. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
Cleophas TJ; Agrawal R; Lichtenthal A; Mäkel W; Fici F
Am J Ther; 2006; 13(3):192-7. PubMed ID: 16772759
[TBL] [Abstract][Full Text] [Related]
35. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients.
Poirier L; Cléroux J; Nadeau A; Lacourcière Y
J Hypertens; 2001 Aug; 19(8):1429-35. PubMed ID: 11518851
[TBL] [Abstract][Full Text] [Related]
36. Early effects of treatment with nebivolol and quinapril on endothelial function in patients with hypertension.
Korkmaz H; Karaca I; Koç M; Onalan O; Yilmaz M; Bilen MN
Endothelium; 2008; 15(3):149-55. PubMed ID: 18568956
[TBL] [Abstract][Full Text] [Related]
37. Coagulation and fibrinolytic parameters in patients with pulmonary hypertension.
Altman R; Scazziota A; Rouvier J; Gurfinkel E; Favaloro R; Perrone S; Fareed J
Clin Cardiol; 1996 Jul; 19(7):549-54. PubMed ID: 8818435
[TBL] [Abstract][Full Text] [Related]
38. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.
Erdoğan O; Ertem B; Altun A
Anadolu Kardiyol Derg; 2011 Jun; 11(4):310-3. PubMed ID: 21543293
[TBL] [Abstract][Full Text] [Related]
39. [Effect of nebivolol on endothelial function in obese patients with hypertension].
Kovaleva ON; Demidenko AV
Lik Sprava; 2006 Jun; (4):57-61. PubMed ID: 17100242
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
